Primary Site >> Liver Cancer

Gene >> EGLN2

Journal: J Clin Invest. 2007 Sep;117(9):2713-22.
Title: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
Author: Calvisi, Diego F|Ladu, Sara|Gorden, Alexis|Farina, Miriam|Lee, Ju-Seog|Conner, Elizabeth A|Schroeder, Insa|Factor, Valentina M|Thorgeirsson, Snorri S
PMID: 17717605
Journal: Cancer Res. 2012 Dec 1;72(23):6163-72.
Title: An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk.
Author: Zhu, Zhansheng|Gao, Xueren|He, Yan|Zhao, Hua|Yu, Qiang|Jiang, Deke|Zhang, Pingzhao|Ma, Xiaopin|Huang, Huixing|Dong, Dong|Wan, Jiao|Gu, Zhenyong|Jiang, Xinghong|Yu, Long|Gao, Yuzhen
PMID: 23026137
Journal: Ann Surg. 2017 Apr;265(4):782-791.
Title: Prolyl Hydroxylase Inhibition Enhances Liver Regeneration Without Induction of Tumor Growth.
Author: Harnoss, Jonathan M|Platzer, Lisa K|Burhenne, Juergen|Radhakrishnan, Praveen|Cai, Jun|Strowitzki, Moritz J|Weiss, Johanna|Ritter, Alina Sophia|Mollenhauer, Martin|Schmidt, Thomas|Ulrich, Alexis|Haefeli, Walter Emil|Schneider, Martin
PMID: 28266966